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Background
Humoral immune responses elicited by an HIV vaccine
would ideally be comprised of durable high titers of
broadly neutralizing antibodies. Importantly, recent studies
of broadly neutralizing antibodies isolated from infected
patients have suggested that high degrees of somatic
hypermutation (SHM) are a common feature of antibodies
with high potency and good breadth. Thus, a successful
vaccine will likely require both immunogens capable of
focusing the humoral response against conserved neutra-
lizing epitopes and appropriate adjuvants/delivery systems
capable of promoting elevated SHM and lasting responses
against these epitopes.
Methods
We generated a small library of gp120 mutants engineered
to have diverse surface compositions but a conserved CD4
binding pocket recognized by the broadly neutralizing
antibody VRC01. These gp120 mutants were linked to
“stealth” liposomes via 2KDa PEG linkers. These lipid
nanoparticles were simultaneously loaded with immunos-
timulatory adjuvant molecules such as MPLA (TLR4 ago-
nist) or CpG (TLR9 agonist) to support differentiation of
helper T-cells and promote avidity maturation of the anti-
body response. Mice were immunized repeatedly with
stealth liposomes carrying unique gp120 mutants in each
boost.
Results
Stealth liposomes carrying TLR4 agonists (TLRa) pro-
moted long-lived humoral responses against env anti-
gens superior to traditional adjuvants such as alum,
montanide, or soluble protein mixed with TLRa. Studies
of liposome/antigen trafficking in vivo suggest these
enhanced responses reflect efficient trafficking of these
nanoparticle vectors to lymph nodes. Notably, this het-
erologous immunization strategy elicited anti-gp120 sera
focused almost exclusively on the CD4 binding site and
that competed with VRC01 for binding to gp120.
Conclusion
This approach of combined immunogen design with
effective multivalent, nanoparticle-based antigen delivery
may provide a strategy to promote strong and long-lived
neutralizing antibody responses against HIV.
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